Biological data sciences in genome research by Schatz,  M. C.
Biological data sciences in genome research
Michael C. Schatz
Simons Center for Quantitative Biology, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724, USA
The last 20 years have been a remarkable era for biology and medicine. One of the most significant achievements has been
the sequencing of the first human genomes, which has laid the foundation for profound insights into human genetics, the
intricacies of regulation and development, and the forces of evolution. Incredibly, as we look into the future over the next
20 years, we see the very real potential for sequencing more than 1 billion genomes, bringing even deeper insight into hu-
man genetics as well as the genetics of millions of other species on the planet. Realizing this great potential for medicine and
biology, though, will only be achieved through the integration and development of highly scalable computational and
quantitative approaches that can keep pace with the rapid improvements to biotechnology. In this perspective, I aim to chart
out these future technologies, anticipate the major themes of research, and call out the challenges ahead. One of the largest
shifts will be in the training used to prepare the class of 2035 for their highly interdisciplinary world.
Modern quantitative biology is in some regards no different than
previous eras. At its core, it follows the same principles as ever
by asking questions of a biological system, and then recording
and integrating observationsmade under varying conditions until
some conclusion can be made. Consider, for example, how the
very foundation of modern genetics, Mendel’s principles of inher-
itance, was established through an analysis of some 30,000 pea
plants and in recognizing the inheritance of certain traits could
be explained by a few simple mathematical rules (Mendel 1866).
This accomplishment demonstrates the power of quantitative
biology, especially considering that these laws were established
in advance of modern molecular biology, including deciphering
how genes encode for proteins or even that DNA is the modality
of inheritance.
What is new in the modern era is, unlike Mendel and his
successors that collected data by hand, the methods for collecting
observations are now largely automated digital sensors. This in-
cludes the rise of DNA sequencing instruments, super-resolution
digital microscopy, mass spectrometry, magnetic resonance imag-
ery, or even satellite imagery used for studying biological sys-
tems with greater throughput and resolution than ever before.
Furthermore, although the instruments are now providing great
quantitiesofdata, theydonotby themselvesdoanymeaningful in-
terpretation of them. Consequently, the second major advance in
the field has been the increased importance of computational
and analytical techniques used to study biological data. These ap-
proaches, including large-scale multicore computing systems, ad-
vanced search and indexing algorithms, numerical optimization
and modeling techniques, and many others, have primarily origi-
nated outside of biology in other quantitative disciplines. This
new paradigm, often called “Biological Data Science” acknowl-
edges that computer science, mathematics, physics, statistics, and
other quantitative fields have developed advanced techniques
that can be applied toward understanding biological data (https://
datascience.nih.gov/).
The power of this approach comes from its ability to find re-
lationships over very large numbers of observations, commonly
stored in terabytes or petabytes of data (Marx 2013). However, giv-
en the size and complexities of the relationships, this pursuit
requires an end-to-end integration of approaches, forming an anal-
ysis stack starting with data collection and continuing through
computational and statistical evaluations toward higher-level bio-
logical interpretations and insights (Fig. 1). Neglecting any layer of
this stack will limit progress toward the higher goals: The instru-
ments do not interpret data, the data will be inaccessible without
high performance computing systems, and abstract quantitative
approaches can be misled by technical artifacts or spurious corre-
lations without a deep understanding of the underlying biology.
Consequently, many of the future advances in biology and medi-
cine will come from the integration of biotechnologies, computa-
tional technologies, and quantitative reasoning, all designed by
scientists with broad training.
With this powerful combination of rapidly advancing bio-
technology and rapidly advancing data science, quantitative biol-
ogy has a very bright future over the next 20 years. Many
fundamental questions in genomics and biologywill start to be ad-
dressed regarding the structure and function of genomes, the mo-
lecular interplay within cells and organs, and the properties of
entire species and ecosystems. One likely outcome from this re-
searchwithin human genetics will be an extended family tree link-
ing together much of the world’s population, and with it,
unprecedented power to study the forces of inheritance as well
as our own origins (Ledford 2013). As we become more capable
at interpreting genomes and monitoring molecular changes, we
will also see profound advances in themedical community toward
recognizing genetic risk factors and treating diseases based on
one’s personal genomic makeup (Collins and Varmus 2015).
Outside of human genetics, we will see major efforts to use quan-
titative biology to enhance agriculture (McCouch et al. 2013),
monitor the microbiome (The Human Microbiome Project
Consortium 2012), or understand the brain (Insel et al. 2013),
among many other projects.
In this perspective, I aim to chart out the major advances and
challenges in quantitative biology in genome research over the
next 20 years, including an analysis of what new biotechnologies
and analytical tools are expected to develop, alongwith how those
developments will lead to advances in biology and medicine. We
end with a look into what technological and societal challenges
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remain ahead, especially the shift in education that is needed to
support the next generation of quantitative biologists.
Advances in biotechnology
Quantitative biology is becoming an increasingly data-rich disci-
pline, especially in the fields of genomics, systems biology, and
computational neuroscience. Each of these fields has benefited tre-
mendously from recent improvements to sensor technology to
probe into the inner workings of cells with increasingly greater res-
olution. Interestingly, many of these advances have benefited
from the core improvements toCCD technology, leading to higher
resolution and more affordable digital photography. These have
naturally translated into improved microscopy or cytometry but
have had far-reaching benefits in other areas. For example, within
DNA sequencing, improved CCD technology has enabled se-
quencing greater numbers and densities of molecules with fluores-
cently tagged nucleotides (Ansorge 2009).
A premier example of how improvedbiotechnologyhas accel-
erated biology has been the development of high-throughput
DNA sequencing. Originally developed in the 1970s, the initial
protocols for sequencing DNA were slow and laborious with haz-
ardous reagents (Sanger and Coulson 1975). These protocols
were revolutionary at the time, but could only reliably sequence
a few hundred or a few thousand base pairs per week per person,
with substantial labor and reagent costs involved. In the past
20 years, however, several fully automated digital instruments
have become commercially available that have dramatically accel-
erated the pace of sequencing (Reuter et al. 2015). During this time,
the worldwide capacity for sequencing DNA has doubled approx-
imately every nine to 12 months; remarkably, the trillionfold
improvements to throughput have beenmatched by similar reduc-
tions in costs. Today, the most powerful sequencing instrument
available, the Illumina X10, can sequence the equivalent of one
haploid human genome everyminute (3 Gbp/min) and has capac-
ity to sequence 18,000 whole human genomes per year to deep
coverage for about $1000 each (Illumina 2015).
Furthermore, the technologies used for sequencingDNAhave
been cleverly repurposed for several other applications. This in-
cludes protocols for measuring the levels of mRNA transcription
or translation inside of cells (RNA-seq, Ribo-seq), the presence of
methylation (Methyl-seq), or the location and frequency of pro-
teins binding to DNA (ChIP-seq), among dozens of other “omics”
assays (Soon et al. 2013). Significant developments have also
pushed these technologies into evermoreminute samples, includ-
ing techniques to measure the genomes, transcriptomes, and
epigenomes of individual cells, especially to probe the heterogene-
ity of gametes, cancer, the brain, and other complex samples
(Wigler 2012).
Consequently, genomics is now a data-rich and diverse sub-
field within modern quantitative biology, with studies exploring
nearly every branch of the tree of life. There are sequencing in-
struments in more than 60 different countries on nearly every
continent (Stephens et al. 2015), and the worldwide sequenc-
ing capacity currently exceeds 35 petabases a year (35 million bil-
lion bases a year), enough capacity to sequence approximately
250,000 human genomes per year (Regalado 2014). Much of that
capacity is concentrated at research institutions, hospitals, and ag-
ricultural companies and is used to study the genetics of humans
and other species, especially those species with medical, agricul-
tural, or bioenergy importance. The sequencing company,
Illumina, projects sequencing capacities will continue to double
year over year and projects that by the end of 2017 more than
1.6 million human genomes will be sequenced (Regalado 2014).
Remarkably, at that rate of growth, over the next 20 years the
worldwide sequencing capacity will grow to reachmore than 1 bil-
lion human genomes per year (Stephens et al. 2015).
It is most likely that human and medical genomics, along
with the genomics of agriculture and energy production, will
come to dominate the sequencing field as they have the largest
economic incentives. In addition to widespread DNA sequencing,
the various “omics” assays will become increasingly important for
monitoring health and disease over time, perhaps even daily mea-
surements to one’s own molecular profile as the technologies be-
come cheaper and more accessible (Chen et al. 2012). This will
be used, for example, to monitor diseases and recommend treat-
ments based on changes to gene expression patterns before any
macroscopic symptoms can be seen (Simon and Roychowdhury
2013). Single-cell approaches will also become increasingly impor-
tant, especially for profiling the heterogeneity in tumors before
and during chemotherapy (Wigler 2012). Electronic medical
records and personalized activity monitors, including Fitbits and
mobile phones, will be used to continuously refine and update
our understanding of our health and behavior (Gottesman et al.
2013).
Outside of medical genomics, many novel applications will
develop as the instrumentation becomes smaller and less expen-
sive (Rusk 2015). One of themost important applications is the for-
mation of a large distributed network of sequencers that can
monitor for potential pathogens around the world. This sensor
network will form the basis for a “digital immune system,” analo-
gous to the worldwide weather network that can recognize chang-
es to the composition of the viruses, microbes, and other agents in
the environment (Schatz and Phillippy 2012). Biological sensors
are already at high profile public sites, such as major sports arenas
and transportation centers, used tomonitor for pathogens passing
in the air. Just as weather prediction becomes more informed and
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Figure 1. Data science analysis stack. Large-scale projects in quantitative
biology must address a multilayer stack of approaches moving toward in-
creasing levels of abstraction. At its base, the experiments begin with the
technologies for collecting data andmetadata from various biological sen-
sors. The processing then proceeds upward through the input/output (IO)
and Compute layers that can support large-scale data processing, statisti-
cal and analysis software layers that can summarize and identify trends in
the data, until finally biological results can be achieved at the top, leverag-
ing the domain knowledge of the problem.
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more accurate by worldwidemonitoring, establishing a worldwide
sequencing net would help us to monitor and contain epidemics
before they can spread to larger populations.
Complementary to the technologies for measuring biological
systems, new technologies formanipulating cells and synthesizing
molecules will also become extremely important. Existing tech-
niques for manipulating DNA or expression levels, such as restric-
tion digests or RNAi (Hannon 2002), will be enhanced with new
higher precision and more flexible technologies. Already,
CRISPR/Cas9 systems are emerging as powerful techniques for ed-
iting genomes (Jinek et al. 2012), and optogenetics can be used for
real-time activation or repression of targeted cells (Deisseroth
2011). Complementary advances in synthetic genomics are start-
ing to yield entirely artificial genomes with genes to produce com-
pounds of our own design (Gibson et al. 2010).
Altogether, the next 20 years holds enormous potential for
sensing and manipulating cells and molecules, creating an effi-
cient feedback cycle between reading a genome ormolecular activ-
ity,modeling its function, andmeasuring the effect of changing it.
Computational and quantitative advances
Most immediately impacted by the massive growth to sequencing
and sensor technologies will be the computational systems used
for storing and transferring biological data. Formore than 20 years,
NCBI and its international counterparts at the EBI and DDBJ have
served as the central clearinghouse for genomic data (NCBI
Resource Coordinators 2015). Over the next 20 years, these re-
sources will continue to steadily grow, although as the sequencing
facilities grow from petabyte to exabyte scale, it will become less
and less practical to transfer data into these archives as they exist
today. Furthermore, as sequencing shifts from research purposes
and into more direct medical applications, the incentive for mak-
ing the data publicly available in a centralized archive will be re-
duced or perhaps even legally restricted.
In its place, wewill see the rise of federated approaches for ex-
changing biological data, especially computing centers dedicated
to large sequencing facilities. Already this trend is beginning,
and the NCBI Sequence Read Archive (SRA) currently only stores
approximately one-tenth of the worldwide sequence production,
∼3.8 Pbp of the >35 Pbp sequenced so far (http://www.ncbi.nlm.
nih.gov/Traces/sra/). Fortunately, the rest of the data are not
completely lost, and we are beginning to see the emergence of
new exchange systems outside of traditional archives. These sys-
tems often consolidate regional and/or topical interests inside a
dedicated cloud-based portal, such as CGHub (Wilks et al. 2014)
or ICGC (The International Cancer Genome 2010) for consolida-
ting cancer genomic data, or the recently launched BGI-Cloud
to provide access to the great resources available there (http
://bgiamericas.com/data-analysis/bgi-cloud/). Illumina BaseSpace
(https://basespace.illumina.com), DNAnexus (https://www.
dnanexus.com/), Google Genomics (https://cloud.google.com/
genomics/), and other commercial vendors are also emerging
to help manage the deluge of data using commercial cloud plat-
forms and are likely to play an increasingly important role in ge-
nomics in the future.
The major technical reason this model will become more
widespread is that at large scales, it is overwhelmingly more effi-
cient to upload code segments, measured in kilobytes to mega-
bytes, rather than to download entire large collections, measured
in petabytes or beyond (Schatz et al. 2010). Economies of scale
are also made possible through consolidating purchasing and
time-sharing of equipment, especially for the many thousands of
cores and petabytes of storage that will need to be purchased
and maintained. It also allows for the different cloud resources
to specialize their services for different biological systems or polit-
ical requirements; despite using common sequencing technolo-
gies, the tools and data sets needed for studying cancer are
very different than those needed for studying crop development,
as are the legal requirements in some countries compared to
others.
Although thismodel of federated cloud-based datawarehous-
ing offers many advantages, it also presents significant new chal-
lenges. Foremost, genomic data are most useful when they can
be aggregated and combined in very large numbers. Otherwise,
subtle genetic signals may be lost if the data are partitioned or
if the measurements are recorded with incompatible formats.
Therefore, the resources will have to establish common applica-
tion programming interfaces (APIs) to enable remote access to
their data, along with strong encryption and authentication safe-
guards to protect from theft or abuse. Today, the Global Alliance
for Genomics and Health is one of the leading efforts to define
such standards for genomics and other personal biomedical data.
Although even the most basic of federated tasks, so-called
“Beacons” that identify if a resource has any individual with a par-
ticular mutation, are proving to be difficult to execute mostly for
nontechnical reasons (http://ga4gh.org/#/beacon). These include
the challenges of agreeing on an API for all institutions to use, pri-
vacy concerns over releasing these data, and a general reluctance to
share unpublished data.
Within each data warehouse there will be major systems en-
gineering challenges to consider: Instead of a program crashing
on one server, a code failure could disrupt thousands of cores at
once leading to years or centuries of wasted computing effort.
Most of the currently available genomics applications are not de-
signed for this level of parallelism, needing new higher-level and
easy-to-use workflow systems to orchestrate the scheduling and
management of resources (Afgan et al. 2011), as well as improved
software engineering practices to build more robust software
(Wilson et al. 2014). Unlike current research practices that often
store all data in a uniformly accessible way, the massive data ware-
housesmust be built with tiered storage systems to prioritize access
to the data within while keeping storage costs manageable
(Haussler et al. 2012). Summary statistics, variant lists, expression
profiles, and other highly processed data can be kept in active
memory, while raw reads and measurements can be archived to
slower and less expensive medium. Specialized data compression
algorithms (Hsi-Yang Fritz et al. 2011), while extremely important
to make the best use of every available byte, are unlikely to
completely solve the storage needs. In an effort to control costs
and complexity, there will be growing urgency to delete data as
soon as possible. This will mark a radical shift in how data are cur-
rently viewed, and requires careful consideration of the “precious-
ness” of a sample: A research project exploring a rare cancer or
ancient DNA sample will likely choose to archive everything,
whereas studies of more abundant samples may elect to only store
the processed results.
The applications and algorithms built for these warehouses
will be focused on integrating the analysis over very large popula-
tions. Certain topics that are widely studied today, such as short-
read mapping or de novo assembly of individual genomes, will
fade away as the algorithms mature and new sequencing technol-
ogies producing longer reads take over, leading to extremely high
quality genomes (Berlin et al. 2015). In its placewill be the need for
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algorithms and systems for studying the genomes, transcriptomes,
and epigenomes of millions of individuals at once, especially sys-
tems that can do so within a graph of sequence variability
(Church et al. 2015). As sequencing becomes more widely used
for real-time applications, such as a real-time readout of the tran-
scription levels in a blood sample, the interpretation can be
done on the fly without the raw data recorded at all. Already sever-
al “streaming” methods for doing this are becoming available for
inferring expression levels from RNA-seq reads that are just as ef-
fective as their more traditional counterparts (Patro et al. 2014),
and other omics data types inferring quantification from sequenc-
es are likely to follow similar developments.
Altogether, over the next 20 years, we will see the develop-
ment of major institutional and governmental data warehousing
for millions to billions of genomes and other biomedical data. It
will require maturing of the algorithms and formats used today
into more scalable and interoperable systems as well as designing
new systems to solve problems that are not even considered today.
A growing need will be for streaming algorithms and other ap-
proaches that can make inferences over diverse data types as
soon as they are produced, so that data storage needs will be as lim-
ited as possible.
Insights of genome research
If one of the greatest accomplishments from the last 20 years has
been sequencing the first human genomes, one of the greatest pur-
suits for the next 20 years will be trying to understand what it all
means. Although we have been quite successful deciphering the
genetic code of how genes code for proteins, the grander challeng-
es of understanding how genome sequences ultimately code for
traits and relate to disease has remained largely a mystery. For
example, the current best estimates suggest several thousands of
variants are related to human height but only a few hundred can-
didates are currently known. Even less is known of the genetic
factors involved in major diseases such as coronary artery dis-
ease (Ozaki and Tanaka 2015) or cerebrovascular disease (Markus
2010) despite strong evidence for a genetic component. Deter-
mining themolecular basis, be it genetic, epigenetic, or evenmeta-
genomic, for these and other human conditions is one of the
central pursuits of quantitative biology and one of the great unan-
swered questions in all of science.
The rationale for sequencing one million or one billion ge-
nomes using this powerful stack of technologies is not to produce
one million or one billion separate lists of variants. Rather, the
hope is that the whole will be greater than the sum of its parts,
and something new will emerge that sheds light on to what those
sequences mean. Like Mendel, the hope is that bringing together
these data will lead to discovering the underlying patterns and
rules of genetics and organism biology: who has which variants,
how they are inherited or evolve, and how variants are related to
diseases and other traits. The insights we will gain will come in
phases depending on several factors, including howmany samples
are available, what other measurements are available, and crucial-
ly, how complex the traits are, ranging from simple monogenic
conditions to highly complex polygenic traits or those with subtle
environmental components (McCarthy et al. 2008). In some cases,
the relationships will be very clear, allowing us to leap almost im-
mediately from genetic variants to their associated traits. More of-
ten thannot, however, this analysis will require a series of stepping
stones to connect how a variant can alter the sequence or expres-
sion of a single gene, which in turn influences a pathway of inter-
connected genes, which then influences the overall cell or
individual, all within a particular environment (Wang et al.
2010a).
Considering the multitude of environmental factors, cell-
type specificities, and diversity of genetic backgrounds, under-
standing what each base of a genome means may be a never-end-
ing pursuit. Nevertheless, over the next 20 years, great strides will
be made in raising our level of understanding. Today, we are most
successful at interpreting major alterations within gene sequences
(Wang et al. 2010b), but we are substantially less informed about
interpreting the relative importance andmechanisms for noncod-
ing mutations (Ward and Kellis 2012). Over the next 20 years,
however, our power for doing so will greatly improve building
on the pioneering work of ENCODE (The ENCODE Project Con-
sortium 2012), the Roadmap Epigenomics Project (Romanoski
et al. 2015), and similar projects that are starting to provide de-
tailed annotations as to the roles and evolution of sequences all
throughout the genome. The community is also currently largely
focused on single nucleotide and other small variants, but as the
sequencing technologies improve, it is likely that the widespread
nature and significance of structural variations will become even
more pronounced (Chaisson et al. 2015). Indeed, although a typ-
ical person has more SNPs than any other class of mutations, the
total number of bases that are mutated, and hence the largest as-
pect of genetic diversity in a person, is mostly due to copy number
and other structural variations (Sebat et al. 2004; Zarrei et al. 2015).
Finally, thewidespread deployment of diverse sensors will allow us
to more carefully consider environmental factors, such as Fitbit-
type data of location and activities integrated with detailedmolec-
ular and microbiome profiles.
Although extremely powerful, caremust be takenwhen using
these data and techniques to avoid unfounded generalizations or
mistaking spurious correlations as causal relationships. Quantita-
tive biology needs integration of quantitative expertise with
domain expertise to design the proper experiments, to fight tech-
nical artifacts, and to recognize relationships outside of the expect-
ed. As recently highlighted, although much scrutiny has been
given to the importance of P-values, these evaluations come at
the top of a complex analysis stack that requires careful scrutiny
at every stage (Leek and Peng 2015). Whenever the result is most
surprising or unexpected, that is exactly when one should be
most critical of themethodology. Caution is also needed to consid-
er the social changes and privacy risks thatwill come frombuilding
these massive data warehouses of personal information, especially
when sequencing a genome becomes as cheap and easy as taking
someone’s photograph. It is surprisingly easy to identify someone
from their genome today andwill become even easier andmore ac-
curate as these massive collections are established (Erlich and
Narayanan 2014). As genome sequences are connected to other
personal data, the threat of genetic discrimination and abuse be-
comes real and everlasting.
Nevertheless, the potential benefits for building and mining
these massive collections are overall much larger than the poten-
tial risks. One of the major lessons learned frommachine learning
has been, when coupledwith the right algorithms and systems, in-
creasing the amount of data often leads to greatly increased perfor-
mance and interpretation, including chess programs (Campbell
et al. 2002), translation systems (Koehn et al. 2007), and even vir-
tual Jeopardy contestants (Ferrucci 2012) that can outperform any
human. Within genomics and quantitative biology, we hope and
anticipate this will prove true as well, leading to many break-
throughs of profound significance over the next 20 years.
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Recommendations for the class of 2035
Children born this summer will grow up in a drastically different
world than those from 20 years ago. They will grow up with un-
precedented access to information, quantitative techniques, and
biotechnologies that will be used tomanipulate biological systems
in currently unimaginable detail. Although the foundations of
biology will continue to be observation, experimentation, and in-
terpretation, the technologies and approaches used will become
ever more powerful and quantitative. More so than ever, we
need to revise the curriculum to integrate computational and
quantitative analysis as early as possible into their training so
they are ready for the world ahead (Schatz 2012).
My recommendation to the next generation of scientists is to
embrace the integration of fields that is forming modern biology.
To be competitive, you will need to establish a broad interdisci-
plinary foundation of math and science as well as strong commu-
nication skills. One of the most important skills you can develop
early is computer programming. Much like learning to speak a
new language is often easier the younger you begin, learning to
“speak” to a computer seems to follow a similar path. Although se-
quencing technologies and other instrumentation will come and
go over the next 20 years, biology will only continue to grow its
dependency on computational analysis as data sets grow ever larg-
er.Mathematicsmay be the language of nature, but code is the lan-
guage of data.
Students should be prepared for the technologies and systems
for coding and data analysis to change over the next two decades,
just as C++ and Python have largely displaced Machine Language
and Fortran in the previous decades. However, as has been broadly
documented in software engineering, while higher-level program-
ming languages, expert systems, and other advanced human-
computing interfaces do simplify and accelerate software develop-
ment, they do not solve the underlying intrinsic complexities of
developing or deciphering large abstract systems (Brooks 1995).
As Fred Brooks so elegantly described it, there is inherently no “sil-
ver bullet” that will make building software easy. All signs indicate
developing software and performing analysis for quantitative biol-
ogy will be at least as difficult, as the number of possible states and
interactions that are potentially relevant to a biological system are
astoundingly large, and we cannot expect any semblance of a de-
signed architecture as we would in an engineered system.
Most of all, I encourage you to follow your sense of curiosity.
The most brilliant advances in science all start with asking the
right questions, especially when encountering something unex-
pected or unexplained. To do so, I also encourage you to learn
the experimental side of biology as early as possible so that you
can pursue your own experiments as you notice something inter-
esting about yourself or the world around you. Many of the most
profound advances have occurred when a new biotechnology
or analysis technique have been applied to a deep biological ques-
tion. When you are first to generate a novel data type you can also
be first to unravel a mystery of how the world operates. Finally,
always remember to keep focused on themost important problems
that you can hope to address.
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